Skip to main content
Clinical Trials/IRCT20190215042716N6
IRCT20190215042716N6
Recruiting
Phase 2

A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital IC

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
62
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age»18 years old
  • Acute patients hospitalized in the intensive care unit (ICU under mechanical ventilation with a ventilator)
  • Patients hospitalized in the intensive care unit without brain damage
  • Is not currently taking any other antidepressants
  • Not pregnant or lactating
  • Willing to sign an informed consent form

Exclusion Criteria

  • Known hypersensitivity to es\-citalopram or any of its components
  • Active suicidal thoughts or behavior
  • Severe liver or kidney failure
  • Uncontrolled arrhythmias
  • Active bleeding History of mania or hypomania
  • Severe personality disorders
  • Current substance abuse or dependence
  • Participation in other clinical trials

Outcomes

Primary Outcomes

Not specified

Similar Trials